Skip to content
Recall Observatory FDA recall evidence

Drug product

Memantine Hydrochloride Extended-Release Capsules, 28 mg, 100 capsules per unit dose cartons, Rx only, Manufactured by: Lupin Limited, Pithampur (M.P.)-454 775, India; Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Dr., Suite 233, Livonia, MI 47152 USA. NDC: 0904-6735-61

D-1262-2020

April 24, 2020

Class III

Product summary

Firm
The Harvard Drug Group
Event
Event 85566
Status
Terminated
Classification
Class III
Quantity
678 cartons
Official record key
drug-enforcement:D-1262-2020

Official wording

Reason: Failed dissolution specifications: Low stage 3 results obtained for dissolution during routine stability testing.

Code information: Lot #: M02199D, M02246D, Exp 5/2020

Distribution pattern: AL, FL, IA, NY, OH, TX

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed dissolution specifications